SPARTEINE OXIDATION POLYMORPHISM - A FAMILY STUDY

被引：23

作者：

BROSEN, K

OTTON, SV

GRAM, LF

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 21卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1986.tb05231.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：661 / 667

页数：7

相关论文

共 15 条

[1] THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE
BERTILSSON, L
ABERGWISTEDT, A
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) : 388 - 390
[2] BROSEN K, 1985, ACTA PHARMACOL TOX, V57, P357
[3] INTER-ETHNIC DIFFERENCE IN SPARTEINE OXIDATION AMONG GHANAIANS AND GERMANS
EICHELBAUM, M
WOOLHOUSE, NM
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (01) : 79 - 83
[4] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[5] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
EICHELBAUM, M
BERTILSSON, L
SAWE, J
ZEKORN, C
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
[6] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
EVANS, DAP
MAHGOUB, A
SLOAN, TP
IDLE, JR
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
[7] THE GENETIC-CONTROL OF SPARTEINE AND DEBRISOQUINE METABOLISM IN MAN WITH NEW METHODS OF ANALYZING BIMODAL DISTRIBUTIONS
EVANS, DAP
HARMER, D
DOWNHAM, DY
WHIBLEY, EJ
IDLE, JR
RITCHIE, J
SMITH, RL
[J]. JOURNAL OF MEDICAL GENETICS, 1983, 20 (05) : 321 - 329
[8] GRAM LF, 1986, CLIN PHARM PSYCHIATR
[9] COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINE
INABA, T
VINKS, A
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) : 394 - 399
[10] KEMP T, 1951, GENETICS HUMAN DISEA, P123